(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1344085 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of STARD13 mRNA CTD PMID:22079256 (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of STARD13 mRNA CTD PMID:25729387 (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE increases expression EXP 6480464 Topotecan results in increased expression of STARD13 mRNA CTD PMID:25729387 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of STARD13 mRNA CTD PMID:25380136 17beta-estradiol increases expression ISO RGD:1344085 6480464 Estradiol results in increased expression of STARD13 mRNA CTD PMID:19619570 17beta-estradiol multiple interactions ISO RGD:1344085 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of STARD13 mRNA CTD PMID:19619570 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1344085 6480464 Dihydrotestosterone results in increased expression of STARD13 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1344085 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of STARD13 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1557364 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of STARD13 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1344085 6480464 Tetrachlorodibenzodioxin results in increased expression of STARD13 mRNA CTD PMID:19619570 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1557364 6480464 Tetrachlorodibenzodioxin affects the expression of STARD13 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1344085 6480464 Tetrachlorodibenzodioxin results in decreased expression of STARD13 mRNA CTD PMID:21296121 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1557364 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of STARD13 mRNA CTD PMID:26251327 3-methylcholanthrene multiple interactions ISO RGD:1344085 6480464 Methylcholanthrene promotes the reaction [AHR protein binds to STARD13 promoter] CTD PMID:20348232 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of STARD13 mRNA CTD PMID:25380136 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of STARD13 mRNA CTD PMID:24780913 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of STARD13 mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO RGD:1344085 6480464 Aflatoxin B1 results in increased expression of STARD13 mRNA CTD PMID:27153756 aflatoxin B1 affects methylation ISO RGD:1344085 6480464 Aflatoxin B1 affects the methylation of STARD13 intron CTD PMID:30157460 aflatoxin B1 decreases methylation ISO RGD:1344085 6480464 Aflatoxin B1 results in decreased methylation of STARD13 gene CTD PMID:27153756 aflatoxin B2 increases methylation ISO RGD:1344085 6480464 aflatoxin B2 results in increased methylation of STARD13 intron CTD PMID:30157460 arsenite(3-) increases methylation ISO RGD:1344085 6480464 arsenite results in increased methylation of STARD13 promoter CTD PMID:23974009 benzo[a]pyrene decreases expression ISO RGD:1344085 6480464 Benzo(a)pyrene results in decreased expression of STARD13 mRNA CTD PMID:22316170 benzo[a]pyrene affects methylation ISO RGD:1344085 6480464 Benzo(a)pyrene affects the methylation of STARD13 intron CTD PMID:30157460 benzo[e]pyrene decreases methylation ISO RGD:1344085 6480464 benzo(e)pyrene results in decreased methylation of STARD13 intron CTD PMID:30157460 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of STARD13 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1344085 6480464 bisphenol A results in decreased expression of STARD13 mRNA CTD PMID:29275510 bisphenol A increases expression ISO RGD:1557364 6480464 bisphenol A results in increased expression of STARD13 mRNA CTD PMID:25594700 butanal decreases expression ISO RGD:1344085 6480464 butyraldehyde results in decreased expression of STARD13 mRNA CTD PMID:26079696 cadmium dichloride affects methylation EXP 6480464 Cadmium Chloride affects the methylation of STARD13 promoter CTD PMID:22457795 carbamazepine affects expression ISO RGD:1344085 6480464 Carbamazepine affects the expression of STARD13 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:1557364 6480464 Nanotubes, Carbon analog results in decreased expression of STARD13 mRNA, Nanotubes, Carbon results in decreased expression of STARD13 mRNA CTD PMID:25554681 chlordecone affects response to substance ISO RGD:1344085 6480464 STARD13 gene SNP affects the susceptibility to Chlordecone CTD PMID:25622337 choline multiple interactions ISO RGD:1557364 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of STARD13 mRNA CTD PMID:20938992 chromium(6+) decreases expression ISO RGD:1344085 6480464 chromium hexavalent ion results in decreased expression of STARD13 mRNA CTD PMID:30690063 ciguatoxin CTX1B affects expression ISO RGD:1557364 6480464 Ciguatoxins affects the expression of STARD13 mRNA CTD PMID:18353800 cisplatin decreases expression ISO RGD:1344085 6480464 Cisplatin results in decreased expression of STARD13 mRNA CTD PMID:27392435 , PMID:27594783 cisplatin multiple interactions ISO RGD:1344085 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of STARD13 mRNA CTD PMID:27392435 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of STARD13 mRNA CTD PMID:24386269 copper(II) sulfate decreases expression ISO RGD:1344085 6480464 Copper Sulfate results in decreased expression of STARD13 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:1344085 6480464 Asbestos, Crocidolite results in increased expression of STARD13 mRNA CTD PMID:18687144 crocidolite asbestos affects methylation ISO RGD:1344085 6480464 Asbestos, Crocidolite affects the methylation of STARD13 5' UTR, Asbestos, Crocidolite affects the methylation of STARD13 gene CTD PMID:29523930 cyclosporin A decreases expression ISO RGD:1344085 6480464 Cyclosporine results in decreased expression of STARD13 mRNA CTD PMID:25562108 , PMID:27989131 dibenz[a,h]anthracene decreases expression ISO RGD:1557364 6480464 1 more ... CTD PMID:26377693 disodium selenite decreases expression ISO RGD:1344085 6480464 Sodium Selenite results in decreased expression of STARD13 mRNA CTD PMID:18175754 doxorubicin affects expression ISO RGD:1344085 6480464 Doxorubicin affects the expression of STARD13 mRNA CTD PMID:29803840 folic acid multiple interactions ISO RGD:1557364 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of STARD13 mRNA CTD PMID:20938992 formaldehyde decreases expression ISO RGD:1344085 6480464 Formaldehyde results in decreased expression of STARD13 mRNA CTD PMID:23416264 furan decreases expression EXP 6480464 furan results in decreased expression of STARD13 mRNA CTD PMID:25539665 , PMID:26194646 genistein decreases methylation EXP 6480464 Genistein results in decreased methylation of STARD13 gene CTD PMID:28505145 hydrogen peroxide affects expression ISO RGD:1344085 6480464 Hydrogen Peroxide affects the expression of STARD13 mRNA CTD PMID:20044591 L-methionine multiple interactions ISO RGD:1557364 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of STARD13 mRNA CTD PMID:20938992 leflunomide increases expression ISO RGD:1344085 6480464 leflunomide results in increased expression of STARD13 mRNA CTD PMID:28988120 , PMID:29427785 methapyrilene decreases methylation ISO RGD:1344085 6480464 Methapyrilene results in decreased methylation of STARD13 intron CTD PMID:30157460 methyl methanesulfonate decreases expression ISO RGD:1344085 6480464 Methyl Methanesulfonate results in decreased expression of STARD13 mRNA CTD PMID:23649840 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of STARD13 mRNA CTD PMID:25380136 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of STARD13 mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:1557364 6480464 Acetaminophen affects the expression of STARD13 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1344085 6480464 Acetaminophen results in decreased expression of STARD13 mRNA CTD PMID:25704631 phosgene affects expression ISO RGD:1557364 6480464 Phosgene affects the expression of STARD13 mRNA CTD PMID:16300373 potassium chromate multiple interactions ISO RGD:1344085 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of STARD13 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1344085 6480464 potassium chromate(VI) results in decreased expression of STARD13 mRNA CTD PMID:22079256 , PMID:22714537 quercetin decreases expression ISO RGD:1344085 6480464 Quercetin results in decreased expression of STARD13 mRNA CTD PMID:21632981 serpentine asbestos increases expression ISO RGD:1344085 6480464 Asbestos, Serpentine results in increased expression of STARD13 mRNA CTD PMID:21148743 silicon dioxide increases expression ISO RGD:1344085 6480464 Silicon Dioxide results in increased expression of STARD13 mRNA CTD PMID:25351596 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of STARD13 mRNA CTD PMID:22110744 sulforaphane decreases expression ISO RGD:1557364 6480464 sulforafan results in decreased expression of STARD13 mRNA CTD PMID:30529165 tamoxifen affects expression ISO RGD:1557364 6480464 Tamoxifen affects the expression of STARD13 mRNA CTD PMID:20937368 topotecan increases expression EXP 6480464 Topotecan results in increased expression of STARD13 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of STARD13 mRNA CTD PMID:25729387 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of STARD13 gene CTD PMID:27618143 trichostatin A increases expression ISO RGD:1344085 6480464 trichostatin A results in increased expression of STARD13 mRNA CTD PMID:24935251 triclosan increases expression ISO RGD:1344085 6480464 Triclosan results in increased expression of STARD13 mRNA CTD PMID:30510588 trimellitic anhydride decreases expression ISO RGD:1557364 6480464 trimellitic anhydride results in decreased expression of STARD13 mRNA CTD PMID:19042947 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1344085 6480464 tris(2-butoxyethyl) phosphate affects the expression of STARD13 mRNA CTD PMID:29024780 valproic acid increases expression ISO RGD:1344085 6480464 Valproic Acid results in increased expression of STARD13 mRNA CTD PMID:24935251 valproic acid affects expression ISO RGD:1344085 6480464 Valproic Acid affects the expression of STARD13 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1557364 6480464 Valproic Acid results in increased expression of STARD13 mRNA CTD PMID:21427059 , PMID:24896083 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of STARD13 mRNA CTD PMID:23034163 zoledronic acid decreases expression ISO RGD:1344085 6480464 zoledronic acid results in decreased expression of STARD13 mRNA CTD PMID:24714768 
Gene-Chemical Interaction Annotations
